Vivani Medical
VANI
28 hedge funds and large institutions have $3.91M invested in Vivani Medical in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 8 closing their positions.
59% more call options, than puts
Call options by funds: $162K | Put options by funds: $102K
0.71% less ownership
Funds ownership: 3.03% → 2.32% (-0.71%)
7% less funds holding
Funds holding: 30 → 28 (-2)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
33% less capital invested
Capital invested by funds: $5.83M → $3.91M (-$1.92M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$244K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$59.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.1K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.4K |
| 5 |
VF
Virtu Financial
New York
|
+$19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$802K |
| 2 |
Morgan Stanley
New York
|
-$666K |
| 3 |
Rafferty Asset Management
New York
|
-$55K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$48.2K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$46K |
VANI Hedge Fund Activity: Q1 2022 in Review
28 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q1 2022, worth a combined $3.91M — down 33% from $5.83M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of VANI and 6 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 7 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $244K. The largest seller was Sabby Management, exiting entirely with an estimated $802K sold.
- 28 institutional investors held Vivani Medical (VANI) as of Q1 2022, down from 30 in Q4 2021.
- Funds reported $3.91M of Vivani Medical stock for Q1 2022, down 33% quarter-over-quarter.
- 6 funds opened new Vivani Medical positions in Q1 2022 and 8 closed out, a net change of -2 holders.
- The largest Vivani Medical buyer in Q1 2022 was Renaissance Technologies, an estimated $244K added.
- The largest Vivani Medical seller in Q1 2022 was Sabby Management, an estimated $802K sold.
Based on aggregated 13F filings for Q1 2022.